Insider Trading disclosures for First Wave BioPharma Inc

The latest disclosure was made by James Sapirstein in First Wave BioPharma Inc where a trade of 174 Common Stock done at an average price of $4.2 was reported to US exchanges on April 1, 2024.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Client Name	Client Category	Action	Reported to Exchange	Quantity	Post Transaction Holding	Traded %	Avg. Price	Value	Security Type
James Sapirstein	Director, Chairman and CEO	Sale of securities on an exchange or to another person at price $ 4.23 per share.	01 Apr 2024	174	37,105 (0%)	0%	4.2	736	Common Stock
Sarah M. Romano	Chief Financial Officer	Sale of securities on an exchange or to another person at price $ 4.23 per share.	01 Apr 2024	75	19,111 (0%)	0%	4.2	317	Common Stock
James Sapirstein	Director, Chairman and CEO	Sale of securities on an exchange or to another person at price $ 4.96 per share.	15 Mar 2024	1,887	37,279 (0%)	0%	5.0	9,360	Common Stock
Sarah M. Romano	Chief Financial Officer	Sale of securities on an exchange or to another person at price $ 4.96 per share.	15 Mar 2024	1,120	19,186 (0%)	0%	5.0	5,555	Common Stock
Chaitan S. Khosla	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	13 Mar 2024	440	440 (0%)	0%		-	Common Stock, par value $0.0001 per share
Chaitan S. Khosla	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	13 Mar 2024	52,980	52,980	-		-	Stock Option (right to buy)
Chaitan S. Khosla	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	13 Mar 2024	140	140	-		-	Series G Non-Voting Convertible Preferred Stock
Jack Syage	Director, President & COO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	13 Mar 2024	4,920	4,920	-		-	Series G Non-Voting Convertible Preferred Stock
Jack Syage	Director, President & COO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	13 Mar 2024	15,400	15,400 (0%)	0%		-	Common Stock, par value $0.0001 per share
Sapirstein James	Director, Chairman, President and CEO	Sale of securities on an exchange or to another person at price $ 4.20 per share.	12 Jan 2024	166	39,166 (0%)	0%	4.2	697	Common Stock
Sarah M. Romano	Chief Financial Officer	Sale of securities on an exchange or to another person at price $ 4.20 per share.	12 Jan 2024	98	20,306 (0%)	0%	4.2	412	Common Stock
Edward Borkowski J.	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2024	19,633	20,248 (0%)	0%		0	Common Stock
Charles J. Casamento	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2024	19,633	19,937 (0%)	0%		0	Common Stock
Alastair Riddell James	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2024	19,633	20,240 (0%)	0%		0	Common Stock
Coelho Mary Theresa	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2024	19,633	20,237 (0%)	0%		0	Common Stock
Sapirstein James	Director, Chairman, President and CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	29 Dec 2023	17,660	19,332 (0%)	0%		0	Common Stock
Sarah Romano M.	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	29 Dec 2023	12,614	13,404 (0%)	0%		0	Common Stock
Sapirstein James	Director, Chairman, President and CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	29 Dec 2023	20,000	39,332 (0%)	0%		0	Common Stock
Sarah M. Romano	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	29 Dec 2023	7,000	20,404 (0%)	0%		0	Common Stock
James Sapirstein	Director, President and CEO	Sale of securities on an exchange or to another person at price $ 1.54 per share.	03 Jul 2023	3,349	36,161 (0%)	0%	1.5	5,157	Common Stock
Sarah M. Romano	Chief Financial Officer	Sale of securities on an exchange or to another person at price $ 1.54 per share.	03 Jul 2023	1,977	17,476 (0%)	0%	1.5	3,045	Common Stock
James Sapirstein	Director, President and CEO	Sale of securities on an exchange or to another person at price $ 2.50 per share.	03 Apr 2023	3,347	39,510 (0%)	0%	2.5	8,368	Common Stock
Sarah M. Romano	Chief Financial Officer	Sale of securities on an exchange or to another person at price $ 2.50 per share.	03 Apr 2023	1,975	19,453 (0%)	0%	2.5	4,938	Common Stock
Charles J. Casamento	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	03 Jan 2023	84,745	85,134 (0%)	0%		0	Common Stock
Edward J. Borkowski	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	03 Jan 2023	84,745	86,156 (0%)	0%		0	Common Stock
Alastair James Riddell	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	03 Jan 2023	84,745	85,185 (0%)	0%		0	Common Stock
James Sapirstein	Director, President and CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	03 Jan 2023	300,000	300,000 (1%)	1%		0	Common Stock
Sarah M. Romano	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	03 Jan 2023	150,000	150,000 (0%)	0%		0	Common Stock
Mary Theresa Coelho	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	03 Jan 2023	84,745	84,745 (0%)	0%		0	Common Stock
David Andrew Hoffman	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	03 Jan 2023	84,745	90,778 (0%)	0%		0	Common Stock
Sarah M. Romano	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Mar 2022	150,000	150,000	-		-	Stock option (right to buy)
Charles J. Casamento	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	03 Jan 2022	34,482	34,482	-		-	Stock option (right to buy)
James E. Pennington	CHIEF MEDICAL OFFICER	Grant, award, or other acquisition of securities at price $ 0.00 per share.	03 Jan 2022	7,500	7,500	-		-	Stock option (right to buy)
Edward J. Borkowski	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	03 Jan 2022	34,482	34,482	-		-	Stock option (right to buy)
Alastair James Riddell	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	03 Jan 2022	34,482	34,482	-		-	Stock option (right to buy)
James Sapirstein	Director, PRES, CEO & CHAIRMAN OF BOARD	Grant, award, or other acquisition of securities at price $ 0.00 per share.	03 Jan 2022	150,000	150,000	-		-	Stock option (right to buy)
Mary Theresa Coelho	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	03 Jan 2022	34,482	34,482	-		-	Stock option (right to buy)
Vern Lee Schramm	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	03 Jan 2022	34,482	34,482	-		-	Stock option (right to buy)
Daniel Schneiderman	CHIEF FINANCIAL OFFICER	Grant, award, or other acquisition of securities at price $ 0.00 per share.	03 Jan 2022	10,000	10,000	-		-	Stock option (right to buy)
Gregory Oakes	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	03 Jan 2022	34,482	34,482	-		-	Stock option (right to buy)
Mary Theresa Coelho	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	09 Sep 2021	10,310	10,310	-		-	Stock option (right to buy)
James E. Pennington	CHIEF MEDICAL OFFICER	Grant, award, or other acquisition of securities at price $ 0.00 per share.	09 Jul 2021	100,000	100,000	-		-	Stock option (right to buy)
James Sapirstein	Director, PRES, CEO & CHAIRMAN OF BOARD	Other type of transaction at price $ 0.00 per share.	30 Jun 2021	900,000	300,000	-		-	Stock options (right to buy)
James Sapirstein	Director, PRES, CEO & CHAIRMAN OF BOARD	Grant, award, or other acquisition of securities at price $ 0.00 per share.	30 Jun 2021	900,000	900,000	-		-	Stock options (right to buy)
Daniel Schneiderman	CHIEF FINANCIAL OFFICER	Grant, award, or other acquisition of securities at price $ 0.00 per share.	30 Jun 2021	35,006	35,006	-		-	Stock option (right to buy)
Daniel Schneiderman	CHIEF FINANCIAL OFFICER	Other type of transaction at price $ 0.00 per share.	30 Jun 2021	35,006	0	-		-	Stock option (right to buy)
Daniel Schneiderman	CHIEF FINANCIAL OFFICER	Other type of transaction at price $ 0.00 per share.	30 Jun 2021	250,000	0	-		-	Stock option (right to buy)
Daniel Schneiderman	CHIEF FINANCIAL OFFICER	Grant, award, or other acquisition of securities at price $ 0.00 per share.	30 Jun 2021	250,000	250,000	-		-	Stock option (right to buy)
Charles J. Casamento	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	04 Jan 2021	41,237	41,237	-		-	Options (right to buy)
Edward J. Borkowski	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	04 Jan 2021	41,237	41,237	-		-	Options (right to buy)
Alastair James Riddell	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	04 Jan 2021	41,237	41,237	-		-	Options (right to buy)
Vern Lee Schramm	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	04 Jan 2021	41,237	41,237	-		-	Options (right to buy)
Gregory Oakes	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	04 Jan 2021	41,237	41,237	-		-	Options (right to buy)
James E. Pennington	CHIEF MEDICAL OFFICER	Grant, award, or other acquisition of securities at price $ 0.00 per share.	16 Jul 2020	300,000	300,000	-		-	Stock option (right to buy)
Edward J. Borkowski	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	16 Jul 2020	46	46	-		-	Series B Convertible Preferred Stock
Edward J. Borkowski	None	Sale or transfer of securities back to the company at price $ 0.00 per share.	16 Jul 2020	100,000	0	-		-	9.0% Senior Convertible Promissory Note
Edward J. Borkowski	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	16 Jul 2020	25,774	25,774	-		-	Exchange Warrants
Edward J. Borkowski	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	16 Jul 2020	230,602	230,602	-		-	Series B Warrants
James Sapirstein	Director, PRESIDENT AND CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	16 Jul 2020	64,935	64,935	-		-	Series B Warrants
James Sapirstein	Director, PRESIDENT AND CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	16 Jul 2020	12	12	-		-	Series B Convertible Preferred Stock
James Sapirstein	Director, PRESIDENT AND CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	16 Jul 2020	1,200,000	1,200,000	-		-	Stock options (right to buy)
Daniel Schneiderman	CHIEF FINANCIAL OFFICER	Grant, award, or other acquisition of securities at price $ 0.00 per share.	16 Jul 2020	35,006	35,006	-		-	Stock option (right to buy)
Daniel Schneiderman	CHIEF FINANCIAL OFFICER	Grant, award, or other acquisition of securities at price $ 0.00 per share.	16 Jul 2020	250,000	250,000	-		-	Stock option (right to buy)
Daniel Schneiderman	CHIEF FINANCIAL OFFICER	Other type of transaction at price $ 0.00 per share.	16 Jul 2020	35,006	300,000	-		-	Stock option (right to buy)
Gregory Oakes	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	13 Apr 2020	60,000	60,000	-		-	Options
Charles J. Casamento	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	06 Apr 2020	80,000	80,000	-		-	Options
Edward J. Borkowski	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	06 Apr 2020	80,000	80,000	-		-	Options
Alastair James Riddell	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	06 Apr 2020	80,000	80,000	-		-	Options
Johan M. Spoor	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	06 Apr 2020	80,000	80,000	-		-	Options
Vern Lee Schramm	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	06 Apr 2020	80,000	80,000	-		-	Options
Charles J. Casamento	None	Gift of securities by or to the insider at price $ 0.00 per share.	19 Mar 2020	9,000	116,998 (0%)	0%		0	Common Stock
Charles J. Casamento	None	Gift of securities by or to the insider at price $ 0.00 per share.	19 Mar 2020	9,000	107,998 (0%)	0%		0	Common Stock
Charles J. Casamento	None	Grant, award, or other acquisition of securities at price $ 0.60 per share.	11 Mar 2020	14,584	108,584 (0%)	0%	0.6	8,750	Common Stock
Charles J. Casamento	None	Grant, award, or other acquisition of securities at price $ 1.04 per share.	11 Mar 2020	8,414	116,998 (0%)	0%	1.0	8,751	Common Stock
Alastair James Riddell	None	Grant, award, or other acquisition of securities at price $ 3.63 per share.	11 Mar 2020	2,755	106,296 (0%)	0%	3.6	10,001	Common Stock
Alastair James Riddell	None	Grant, award, or other acquisition of securities at price $ 4.74 per share.	11 Mar 2020	264	101,034 (0%)	0%	4.7	1,251	Common Stock
Alastair James Riddell	None	Grant, award, or other acquisition of securities at price $ 4.74 per share.	11 Mar 2020	770	100,770 (0%)	0%	4.7	3,650	Common Stock
Alastair James Riddell	None	Grant, award, or other acquisition of securities at price $ 1.04 per share.	11 Mar 2020	8,414	132,049 (0%)	0%	1.0	8,751	Common Stock
Alastair James Riddell	None	Grant, award, or other acquisition of securities at price $ 0.60 per share.	11 Mar 2020	14,584	123,635 (0%)	0%	0.6	8,750	Common Stock
Alastair James Riddell	None	Grant, award, or other acquisition of securities at price $ 3.99 per share.	11 Mar 2020	2,507	103,541 (0%)	0%	4.0	10,003	Common Stock
Vern Lee Schramm	None	Grant, award, or other acquisition of securities at price $ 1.04 per share.	11 Mar 2020	8,414	90,498 (0%)	0%	1.0	8,751	Common Stock
Vern Lee Schramm	None	Grant, award, or other acquisition of securities at price $ 0.60 per share.	11 Mar 2020	14,584	82,084 (0%)	0%	0.6	8,750	Common Stock
Edward J. Borkowski	None	Grant, award, or other acquisition of securities at price $ 4.74 per share.	10 Mar 2020	1,319	403,443 (1%)	0%	4.7	6,252	Common Stock
Edward J. Borkowski	None	Grant, award, or other acquisition of securities at price $ 4.74 per share.	10 Mar 2020	6,330	409,773 (1%)	0%	4.7	30,004	Common Stock
Edward J. Borkowski	None	Grant, award, or other acquisition of securities at price $ 1.04 per share.	10 Mar 2020	8,414	402,124 (1%)	0%	1.0	8,751	Common Stock
Edward J. Borkowski	None	Grant, award, or other acquisition of securities at price $ 0.60 per share.	10 Mar 2020	14,584	393,710 (1%)	0%	0.6	8,750	Common Stock
Daniel Schneiderman	CHIEF FINANCIAL OFFICER	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2020	335,006	335,006	-		-	Options
Charles J. Casamento	Director	Grant, award, or other acquisition of securities at price $ 1.04 per share.	31 Dec 2019	7,500	94,000 (0%)	0%	1.0	7,800	Common Stock
Alastair James Riddell	Director	Grant, award, or other acquisition of securities at price $ 1.04 per share.	31 Dec 2019	7,500	100,000 (0%)	0%	1.0	7,800	Common Stock
Vern Lee Schramm	Director	Grant, award, or other acquisition of securities at price $ 1.04 per share.	31 Dec 2019	7,500	67,500 (0%)	0%	1.0	7,800	Common Stock
Edward J. Borkowski	Director	Grant, award, or other acquisition of securities at price $ 1.04 per share.	20 Dec 2019	7,500	379,126 (1%)	0%	1.0	7,800	Common Stock
Edward J. Borkowski	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Dec 2019	51,547	103,094	-		-	Warrants
James Sapirstein	Director, PRESIDENT AND CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	08 Oct 2019	300,000	300,000	-		-	Options
James Sapirstein	Director, PRESIDENT AND CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	08 Oct 2019	200,000	200,000 (0%)	0%		-	Common Stock
Charles J. Casamento	Director	Grant, award, or other acquisition of securities at price $ 0.60 per share.	30 Sep 2019	7,500	86,500 (0%)	0%	0.6	4,500	Common
Edward J. Borkowski	Director	Grant, award, or other acquisition of securities at price $ 0.60 per share.	30 Sep 2019	7,500	371,626 (1%)	0%	0.6	4,500	Common Stock
Alastair James Riddell	Director	Grant, award, or other acquisition of securities at price $ 0.60 per share.	30 Sep 2019	7,500	92,500 (0%)	0%	0.6	4,500	Common Stock
Vern Lee Schramm	Director	Grant, award, or other acquisition of securities at price $ 0.60 per share.	30 Sep 2019	7,500	60,000 (0%)	0%	0.6	4,500	Common Stock
Charles J. Casamento	Director	Grant, award, or other acquisition of securities at price $ 1.70 per share.	30 Jun 2019	7,500	79,000 (0%)	0%	1.7	12,750	Common
Edward J. Borkowski	Director	Grant, award, or other acquisition of securities at price $ 1.70 per share.	30 Jun 2019	7,500	364,126 (1%)	0%	1.7	12,750	Common Stock
Alastair James Riddell	Director	Grant, award, or other acquisition of securities at price $ 1.70 per share.	30 Jun 2019	7,500	85,000 (0%)	0%	1.7	12,750	Common Stock
Vern Lee Schramm	Director	Grant, award, or other acquisition of securities at price $ 1.70 per share.	30 Jun 2019	7,500	52,500 (0%)	0%	1.7	12,750	Common Stock
Charles J. Casamento	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	13 Jun 2019	30,000	30,000	-		-	Options
James E. Pennington	CHIEF MEDICAL OFFICER	Grant, award, or other acquisition of securities at price $ 0.00 per share.	13 Jun 2019	110,000	110,000	-		-	Stock option (right to buy)
Edward J. Borkowski	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	13 Jun 2019	30,000	30,000	-		-	Options
Alastair James Riddell	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	13 Jun 2019	30,000	30,000	-		-	Options
Vern Lee Schramm	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	13 Jun 2019	30,000	30,000	-		-	Options
Charles J. Casamento	Director	Grant, award, or other acquisition of securities at price $ 2.42 per share.	31 Mar 2019	7,500	71,500 (0%)	0%	2.4	18,150	Common Stock
Edward J. Borkowski	Director	Grant, award, or other acquisition of securities at price $ 2.42 per share.	31 Mar 2019	7,500	356,626 (1%)	0%	2.4	18,150	Common Stock
Alastair James Riddell	Director	Grant, award, or other acquisition of securities at price $ 2.42 per share.	31 Mar 2019	7,500	77,500 (0%)	0%	2.4	18,150	Common Stock
Vern Lee Schramm	Director	Grant, award, or other acquisition of securities at price $ 2.42 per share.	31 Mar 2019	7,500	45,000 (0%)	0%	2.4	18,150	Common Stock
Charles J. Casamento	None	Purchase of securities on an exchange or from another person at price $ 1.41 per share.	28 Dec 2018	9,000	56,500 (0%)	0%	1.4	12,690	Common Stock
Charles J. Casamento	None	Grant, award, or other acquisition of securities at price $ 1.29 per share.	28 Dec 2018	7,500	64,000 (0%)	0%	1.3	9,675	Common Stock
Edward J. Borkowski	None	Grant, award, or other acquisition of securities at price $ 1.29 per share.	28 Dec 2018	7,500	349,126 (1%)	0%	1.3	9,675	Common Stock
Alastair James Riddell	None	Grant, award, or other acquisition of securities at price $ 1.29 per share.	28 Dec 2018	7,500	70,000 (0%)	0%	1.3	9,675	Common Stock
Johan M. Spoor	Director, PRESIDENT AND CEO	Purchase of securities on an exchange or from another person at price $ 1.30 per share.	28 Dec 2018	38,583	338,617 (1%)	0%	1.3	49,969	Common Stock
Maged Shenouda	Director, CHIEF FINANCIAL OFFICER	Purchase of securities on an exchange or from another person at price $ 1.31 per share.	28 Dec 2018	20,000	62,500 (0%)	0%	1.3	26,214	Common Stock
Vern Lee Schramm	None	Grant, award, or other acquisition of securities at price $ 1.29 per share.	28 Dec 2018	7,500	37,500 (0%)	0%	1.3	9,675	Common Stock
Charles J. Casamento	None	Grant, award, or other acquisition of securities at price $ 2.57 per share.	28 Sep 2018	7,500	47,500 (0%)	0%	2.6	19,275	Common Stock
Edward J. Borkowski	None	Grant, award, or other acquisition of securities at price $ 2.57 per share.	28 Sep 2018	7,500	341,626 (2%)	0%	2.6	19,275	Common Stock
Alastair James Riddell	None	Grant, award, or other acquisition of securities at price $ 2.57 per share.	28 Sep 2018	7,500	62,500 (0%)	0%	2.6	19,275	Common Stock
Vern Lee Schramm	None	Grant, award, or other acquisition of securities at price $ 2.57 per share.	28 Sep 2018	7,500	30,000 (0%)	0%	2.6	19,275	Common Stock
James E. Pennington	CHIEF MEDICAL OFFICER	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Jul 2018	75,000	75,000	-		-	Options
Johan M. Spoor	Director, PRESIDENT AND CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Jul 2018	200,000	300,034 (1%)	1%		0	Common Stock
Maged Shenouda	Director, CHIEF FINANCIAL OFFICER	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Jul 2018	100,000	100,000	-		-	Options
Daniel Dupret	CHIEF SCIENTIFIC OFFICER	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Jul 2018	15,000	15,000 (0%)	0%		0	Common Stock
Daniel Dupret	CHIEF SCIENTIFIC OFFICER	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Jul 2018	60,000	60,000	-		-	Options
Charles J. Casamento	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	29 Jun 2018	7,500	40,000 (0%)	0%		0	Common Stock
Edward J. Borkowski	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	29 Jun 2018	7,500	334,126 (1%)	0%		0	Common Stock
Alastair James Riddell	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	29 Jun 2018	7,500	55,000 (0%)	0%		0	Common Stock
Vern Lee Schramm	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	29 Jun 2018	7,500	22,500 (0%)	0%		0	Common Stock
Charles J. Casamento	None	Grant, award, or other acquisition of securities at price $ 3.14 per share.	29 Mar 2018	7,500	32,500 (0%)	0%	3.1	23,550	Common Stock
Edward J. Borkowski	None	Grant, award, or other acquisition of securities at price $ 3.14 per share.	29 Mar 2018	7,500	305,446 (2%)	0%	3.1	23,550	Common Stock
Alastair James Riddell	None	Grant, award, or other acquisition of securities at price $ 3.14 per share.	29 Mar 2018	7,500	47,500 (0%)	0%	3.1	23,550	Common Stock
Vern Lee Schramm	None	Grant, award, or other acquisition of securities at price $ 3.14 per share.	29 Mar 2018	7,500	15,000 (0%)	0%	3.1	23,550	Common Stock
Edward J. Borkowski	None	Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.50 per share.	11 Jan 2018	13,680	305,446 (2%)	0%	2.5	34,200	Common Stock
Edward J. Borkowski	None	Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.50 per share.	11 Jan 2018	13,680	319,126 (2%)	0%	2.5	34,200	Common Stock
Edward J. Borkowski	None	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	11 Jan 2018	13,680	0	-		-	Warrants
Edward J. Borkowski	None	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	11 Jan 2018	8,640	28,474	-		-	Warrants
Edward J. Borkowski	None	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	11 Jan 2018	13,680	0	-		-	Warrants
Edward J. Borkowski	None	Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.50 per share.	11 Jan 2018	8,640	291,766 (2%)	0%	2.5	21,600	Common Stock
Charles J. Casamento	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Dec 2017	7,500	25,000 (0%)	0%		0	Common Stock
Edward J. Borkowski	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Dec 2017	7,500	305,446 (2%)	0%		0	Common Stock
Alastair James Riddell	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Dec 2017	7,500	40,000 (0%)	0%		0	Common Stock
Vern Lee Schramm	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Dec 2017	7,500	7,500 (0%)	0%		0	Common Stock
Johan M. Spoor	Director, PRESIDENT AND CEO		10 Nov 2017	100,000	100,034 (0%)	0%	1	100,000	Common Stock
Johan M. Spoor	Director, PRESIDENT AND CEO		10 Nov 2017	100,000	200,000	-		-	Options
Charles J. Casamento	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	19 Oct 2017	17,500	17,500 (0%)	0%		0	Common Stock
Edward J. Borkowski	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	19 Oct 2017	22,500	275,626 (2%)	0%		0	Common Stock
Alastair James Riddell	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	19 Oct 2017	22,500	32,500 (0%)	0%		0	Common Stock
Maged Shenouda	Director, CHIEF FINANCIAL OFFICER	Grant, award, or other acquisition of securities at price $ 0.00 per share.	19 Oct 2017	22,500	42,500 (0%)	0%		0	Common Stock
Maged Shenouda	Director, CHIEF FINANCIAL OFFICER	Grant, award, or other acquisition of securities at price $ 0.00 per share.	25 Sep 2017	100,000	100,000	-		-	Options
Edward J. Borkowski	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	03 Feb 2017	30,000	30,000	-		-	Options
Alastair James Riddell	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	03 Feb 2017	30,000	30,000	-		-	Options
Johan M. Spoor	Director, PRESIDENT AND CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	03 Feb 2017	100,000	100,000	-		-	Options
Maged Shenouda	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	03 Feb 2017	30,000	30,000	-		-	Options

*All Values are in $ Million

Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures

Data as reported to USA Exchanges

View All The Insider Trades disclosures

Insider Trading disclosures for First Wave BioPharma Inc

The latest disclosure was made by James Sapirstein in First Wave BioPharma Inc where a trade of 174 Common Stock done at an average price of $4.2 was reported to US exchanges on April 1, 2024.

Screeners based on Insider Trading and SAST parameters